Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obstetrics | 2 | 2014 | 80 | 0.780 |
Why?
|
| Diabetes, Gestational | 3 | 2023 | 138 | 0.510 |
Why?
|
| Fetal Blood | 2 | 2013 | 70 | 0.470 |
Why?
|
| Obstetric Labor, Premature | 3 | 2024 | 31 | 0.430 |
Why?
|
| Blood Banks | 1 | 2013 | 7 | 0.420 |
Why?
|
| Health Policy | 1 | 2014 | 177 | 0.390 |
Why?
|
| Physician's Role | 1 | 2013 | 120 | 0.380 |
Why?
|
| Prediabetic State | 2 | 2022 | 51 | 0.370 |
Why?
|
| Pregnancy | 11 | 2024 | 2219 | 0.290 |
Why?
|
| Taste Buds | 1 | 2024 | 4 | 0.220 |
Why?
|
| Uterine Contraction | 1 | 2024 | 11 | 0.220 |
Why?
|
| Hypoglycemia | 1 | 2023 | 66 | 0.200 |
Why?
|
| Myometrium | 2 | 2024 | 15 | 0.200 |
Why?
|
| Infant, Newborn | 7 | 2024 | 1286 | 0.190 |
Why?
|
| Pre-Eclampsia | 1 | 2023 | 70 | 0.190 |
Why?
|
| Insulins | 1 | 2021 | 15 | 0.190 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2024 | 124 | 0.180 |
Why?
|
| Glucose Intolerance | 1 | 2021 | 88 | 0.180 |
Why?
|
| Pregnancy Outcome | 3 | 2023 | 181 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2023 | 605 | 0.150 |
Why?
|
| Female | 11 | 2024 | 30779 | 0.110 |
Why?
|
| Delivery, Obstetric | 1 | 2014 | 51 | 0.110 |
Why?
|
| Public Sector | 1 | 2013 | 13 | 0.100 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1992 | 5 | 0.100 |
Why?
|
| Pregnancy, Animal | 1 | 1992 | 9 | 0.100 |
Why?
|
| Humans | 12 | 2024 | 59479 | 0.100 |
Why?
|
| Uterus | 1 | 1992 | 40 | 0.100 |
Why?
|
| Placenta | 1 | 1992 | 55 | 0.090 |
Why?
|
| Fetal Macrosomia | 1 | 1991 | 12 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2013 | 256 | 0.090 |
Why?
|
| Phenanthrolines | 2 | 2024 | 10 | 0.090 |
Why?
|
| Oxygen Consumption | 1 | 1992 | 207 | 0.090 |
Why?
|
| Anemia | 1 | 1992 | 119 | 0.090 |
Why?
|
| Oxytocin | 2 | 2024 | 45 | 0.090 |
Why?
|
| Blood Glucose | 2 | 2023 | 461 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1554 | 0.090 |
Why?
|
| Calcium | 2 | 2024 | 557 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2023 | 6088 | 0.070 |
Why?
|
| Hormones | 1 | 2005 | 60 | 0.060 |
Why?
|
| Endothelin-1 | 1 | 2024 | 7 | 0.060 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2024 | 7 | 0.060 |
Why?
|
| Genitalia | 1 | 2024 | 9 | 0.060 |
Why?
|
| Dinoprost | 1 | 2024 | 19 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2008 | 366 | 0.050 |
Why?
|
| Taste | 1 | 2024 | 33 | 0.050 |
Why?
|
| Semen | 1 | 2024 | 42 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2005 | 276 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2023 | 163 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2023 | 192 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2021 | 91 | 0.050 |
Why?
|
| Parturition | 1 | 2021 | 52 | 0.050 |
Why?
|
| Pregnant Women | 1 | 2021 | 84 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 444 | 0.040 |
Why?
|
| Insulin | 1 | 2023 | 672 | 0.040 |
Why?
|
| Transducin | 1 | 2017 | 7 | 0.040 |
Why?
|
| Magnesium Sulfate | 1 | 2017 | 8 | 0.040 |
Why?
|
| Albuterol | 1 | 2017 | 24 | 0.030 |
Why?
|
| Chloroquine | 1 | 2017 | 50 | 0.030 |
Why?
|
| Mice | 2 | 2024 | 10308 | 0.030 |
Why?
|
| United States | 3 | 2023 | 7431 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2017 | 29 | 0.030 |
Why?
|
| Risk Factors | 2 | 2023 | 4991 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2017 | 137 | 0.030 |
Why?
|
| Animals | 3 | 2024 | 19677 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2017 | 197 | 0.030 |
Why?
|
| Neoplasms | 1 | 2005 | 1233 | 0.030 |
Why?
|
| Birth Injuries | 1 | 1991 | 2 | 0.020 |
Why?
|
| Dystocia | 1 | 1991 | 2 | 0.020 |
Why?
|
| Shoulder Injuries | 1 | 1991 | 10 | 0.020 |
Why?
|
| Trial of Labor | 1 | 1991 | 7 | 0.020 |
Why?
|
| Sheep | 1 | 1992 | 171 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1991 | 103 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1991 | 39 | 0.020 |
Why?
|
| Labor, Induced | 1 | 1991 | 25 | 0.020 |
Why?
|
| Birth Weight | 1 | 1991 | 81 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1992 | 230 | 0.020 |
Why?
|
| Cesarean Section | 1 | 1991 | 95 | 0.020 |
Why?
|
| Chronic Disease | 1 | 1992 | 717 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 2008 | 56 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2005 | 54 | 0.010 |
Why?
|
| Gestational Age | 1 | 2005 | 180 | 0.010 |
Why?
|
| Smoking | 1 | 2008 | 826 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2005 | 343 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2005 | 151 | 0.010 |
Why?
|
| Adult | 1 | 2008 | 15704 | 0.010 |
Why?
|
| Male | 1 | 2005 | 27794 | 0.000 |
Why?
|